Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD) Clinical Trials in Edison, New Jersey

A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD